Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cantor Fitzgerald Downgrades Asensus Surgical to Neutral

Author: Benzinga Newsdesk | November 16, 2023 07:12am
Cantor Fitzgerald analyst Ross Osborn downgrades Asensus Surgical (AMEX:ASXC) from Overweight to Neutral.

Posted In: ASXC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist